Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Mar;13(3):1507-15.
doi: 10.1128/mcb.13.3.1507-1515.1993.

Retroposition in a family of carcinoma-associated antigen genes

Affiliations

Retroposition in a family of carcinoma-associated antigen genes

A J Linnenbach et al. Mol Cell Biol. 1993 Mar.

Abstract

The gene encoding the carcinoma-associated antigen defined by the monoclonal antibody GA733 is a member of a family of at least two type I membrane proteins. This study describes the mechanism of evolution of the GA733-1 and GA733-2 genes. A full-length cDNA clone for GA733-1 was obtained by screening a human placental library with a genomic DNA probe. Comparative analysis of the cDNA sequence with the previously determined genomic sequence confirmed that GA733-1 is an intronless gene. The GA733-2 gene encoding the monoclonal antibody-defined antigen was molecularly cloned with a cDNA probe and partially sequenced. Comparison of GA733-2 gene sequences with the previously established cDNA sequence revealed that this gene consists of nine exons. The putative promoter regions of the GA733-1 and GA733-2 genes are unrelated. These findings suggest that the GA733-1 gene was formed by the retroposition of the GA733-2 gene via an mRNA intermediate. Prior to retroposition, the GA733-2 gene had been affected by exon shuffling. Analysis of GA733-2 exons revealed that many delineate structural motifs. The GA733-1 retroposon was localized either to chromosome region 1p32-1p31 or to 1p13-1q12, and the GA733-2 founder gene was localized to chromosome 4q.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6833-7 - PubMed
    1. Proc Natl Acad Sci U S A. 1990 May;87(9):3542-6 - PubMed
    1. Biochem Biophys Res Commun. 1991 Nov 27;181(1):184-90 - PubMed
    1. J Immunol. 1992 Jan 15;148(2):590-6 - PubMed
    1. Cancer Res. 1992 Feb 15;52(4):815-21 - PubMed

Publication types

Substances